Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience

BACKGROUND: The aim of our study was to evaluate the safety and efficacy of triple therapy using boceprevir (BOC) with pegylated interferon (pIFN)/ribavirin (RBV) in chronic hepatitis C (CHC) genotype 1 (G1) treatment-experienced patients with advanced fibrosis or compensated cirrhosis. METHODS: We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Gastroenterol
Autors principals: Manolakopoulos, Spilios, Kranidioti, Hariklia, Goulis, John, Vlachogiannakos, John, Elefsiniotis, John, Kouroumalis, Elias A., Koskinas, John, Kontos, George, Evangelidou, Eftychia, Doumba, Polyxeni, Sinakos, Emmanuel, Vafiadou, Ιrini, Koulentaki, Mairi, Papatheodoridis, George, Akriviadis, Evangelos
Format: Artigo
Idioma:Inglês
Publicat: Hellenic Society of Gastroenterology 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4585396/
https://ncbi.nlm.nih.gov/pubmed/26423714
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars